Helius Medical Technologies Future Growth
Future criteria checks 2/6
Helius Medical Technologies's earnings are forecast to decline at 28.9% per annum while its annual revenue is expected to grow at 55.5% per year. EPS is expected to grow by 66.2% per annum.
Key information
-28.9%
Earnings growth rate
66.2%
EPS growth rate
| Medical Equipment earnings growth | 15.9% |
| Revenue growth rate | 55.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 13 Aug 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 1 | -14 | N/A | N/A | 1 |
| 12/31/2024 | 1 | -11 | N/A | N/A | 1 |
| 6/30/2024 | 1 | -9 | -10 | -10 | N/A |
| 3/31/2024 | 1 | -9 | -10 | -10 | N/A |
| 12/31/2023 | 1 | -9 | -10 | -10 | N/A |
| 9/30/2023 | 1 | -13 | -11 | -11 | N/A |
| 6/30/2023 | 1 | -10 | -12 | -12 | N/A |
| 3/31/2023 | 1 | -12 | -13 | -13 | N/A |
| 12/31/2022 | 1 | -14 | -14 | -14 | N/A |
| 9/30/2022 | 1 | -13 | -16 | -16 | N/A |
| 6/30/2022 | 1 | -17 | -15 | -15 | N/A |
| 3/31/2022 | 1 | -19 | -15 | -15 | N/A |
| 12/31/2021 | 1 | -18 | -13 | -13 | N/A |
| 9/30/2021 | 0 | -17 | -12 | -12 | N/A |
| 6/30/2021 | 0 | -15 | -12 | -11 | N/A |
| 3/31/2021 | 1 | -13 | -11 | -11 | N/A |
| 12/31/2020 | 1 | -14 | -12 | -12 | N/A |
| 9/30/2020 | 1 | -17 | -14 | -14 | N/A |
| 6/30/2020 | 1 | -19 | -17 | -17 | N/A |
| 3/31/2020 | 1 | -16 | -18 | -18 | N/A |
| 12/31/2019 | 1 | -10 | -21 | -21 | N/A |
| 9/30/2019 | 2 | -10 | -22 | -22 | N/A |
| 6/30/2019 | 2 | -8 | -20 | -20 | N/A |
| 3/31/2019 | 1 | -26 | -22 | -22 | N/A |
| 12/31/2018 | 0 | -29 | -20 | -20 | N/A |
| 9/30/2018 | N/A | -27 | -20 | -20 | N/A |
| 6/30/2018 | N/A | -36 | -21 | -21 | N/A |
| 3/31/2018 | N/A | -24 | N/A | -21 | N/A |
| 12/31/2017 | N/A | -28 | N/A | -19 | N/A |
| 9/30/2017 | N/A | -30 | N/A | -18 | N/A |
| 6/30/2017 | N/A | -20 | N/A | -15 | N/A |
| 3/31/2017 | N/A | -18 | N/A | -11 | N/A |
| 12/31/2016 | N/A | -16 | N/A | -10 | N/A |
| 9/30/2016 | N/A | -12 | N/A | -9 | N/A |
| 6/30/2016 | N/A | -7 | N/A | -8 | N/A |
| 3/31/2016 | N/A | -7 | N/A | -8 | N/A |
| 12/31/2015 | N/A | -5 | N/A | -8 | N/A |
| 9/30/2015 | N/A | -5 | N/A | -7 | N/A |
| 6/30/2015 | N/A | -11 | N/A | -8 | N/A |
| 3/31/2015 | N/A | -10 | N/A | -6 | N/A |
| 12/31/2014 | N/A | -8 | N/A | -5 | N/A |
| 9/30/2014 | N/A | -6 | N/A | -3 | N/A |
| 6/30/2014 | N/A | -3 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 26H is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 26H is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 26H is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 26H's revenue (55.5% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: 26H's revenue (55.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 26H's Return on Equity is forecast to be high in 3 years time